Diabetes Increases PM2.5 Sensitivity and Bone Marrow Aging in New Study
A study reveals that diabetes exacerbates the negative health impacts of PM2.5 exposure, leading to faster bone marrow stem cell degradation and…
A study reveals that diabetes exacerbates the negative health impacts of PM2.5 exposure, leading to faster bone marrow stem cell degradation and…
Eli Lilly's retatrutide trial data shows a 2.2% A1C reduction and up to 21% weight loss, significantly outpacing Novo Nordisk's Ozempic in…
Eli Lilly's oral GLP-1 drug orforglipron demonstrates significant cardiovascular safety and efficacy in phase 3 trials, showing a 16% lower risk of…
Eli Lilly's EloraTZP trial results show a 23.3% average weight loss, signaling a potential new benchmark in the company's obesity and type…